Samuel J. Balin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samuel J. Balin has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- David I. Weiss
David Geffen School of Medicine at UCLA, Los Angeles, USA
2 shared publications - Maria Teresa Ochoa
Department of Dermatology, University of Southern California School of Medicine, Los Angeles, California, United States of America
2 shared publications - Matteo Pellegrini
Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, USA
2 shared publications - Robert L. Modlin
Division of Dermatology, Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA
2 shared publications Aaron W. Choi
Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
1 shared publication- Adrienne Grzenda
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles
1 shared publication
Latest Publications
- 1 April 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (4) , 764-773.e4
Defining Transcriptional Signatures of Human Hair Follicle Cell States
- 1 April 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (4) , 764-773.e4
Defining Transcriptional Signatures of Human Hair Follicle Cell States
- Open Access
- 15 August 2019
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 203 (4) , 911-921
IL-1β Induces the Rapid Secretion of the Antimicrobial Protein IL-26 from Th17 Cells
Th17 cells play a critical role in the adaptive immune response against extracellular bacteria, and the possible mechanisms by which they can protect against infection are of particular interest. In this study, we describe, to our knowledge, a novel IL-1β dependent pathway for secretion of the antimicrobial peptide IL-26 from human Th17 cells that is independent of and more rapid than classical TCR activation. We find that IL-26 is secreted 3 hours after treating PBMCs with Mycobacterium leprae as compared with 48 hours for IFN-γ and IL-17A. IL-1β was required for microbial ligand induction of IL-26 and was sufficient to stimulate IL-26 release from Th17 cells. Only IL-1RI+ Th17 cells responded to IL-1β, inducing an NF-κB–regulated transcriptome. Finally, supernatants from IL-1β–treated memory T cells killed Escherichia coli in an IL-26–dependent manner. These results identify a mechanism by which human IL-1RI+ “antimicrobial Th17 cells” can be rapidly activated by IL-1β as part of the innate immune response to produce IL-26 to kill extracellular bacteria. Key Points TLR ligands induce IL-26 secretion from PBMCs in an IL-1β–dependent manner. IL-1β induces rapid IL-26 release by IL-1RI+ Th17 cells without TCR activation. IL-1β–stimulated T cells mediate an antimicrobial activity via IL-26.
- 15 August 2019
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 203 (4) , 911-921
Open AccessIL-1β Induces the Rapid Secretion of the Antimicrobial Protein IL-26 from Th17 Cells
Th17 cells play a critical role in the adaptive immune response against extracellular bacteria, and the possible mechanisms by which they can protect against infection are of particular interest. In this study, we describe, to our knowledge, a novel IL-1β dependent pathway for secretion of the antimicrobial peptide IL-26 from human Th17 cells that is independent of and more rapid than classical TCR activation. We find that IL-26 is secreted 3 hours after treating PBMCs with Mycobacterium leprae as compared with 48 hours for IFN-γ and IL-17A. IL-1β was required for microbial ligand induction of IL-26 and was sufficient to stimulate IL-26 release from Th17 cells. Only IL-1RI+ Th17 cells responded to IL-1β, inducing an NF-κB–regulated transcriptome. Finally, supernatants from IL-1β–treated memory T cells killed Escherichia coli in an IL-26–dependent manner. These results identify a mechanism by which human IL-1RI+ “antimicrobial Th17 cells” can be rapidly activated by IL-1β as part of the innate immune response to produce IL-26 to kill extracellular bacteria. Key Points TLR ligands induce IL-26 secretion from PBMCs in an IL-1β–dependent manner. IL-1β induces rapid IL-26 release by IL-1RI+ Th17 cells without TCR activation. IL-1β–stimulated T cells mediate an antimicrobial activity via IL-26.
- 3 August 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 3 (26)
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria
Intracellular bacteria are killed by human antimicrobial CD8 + T cells that express NKG2C and secrete granzyme B, perforin, and granulysin.
- 3 August 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 3 (26)
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria
Intracellular bacteria are killed by human antimicrobial CD8 + T cells that express NKG2C and secrete granzyme B, perforin, and granulysin.